Gut health formula tested for bowel disease relief
NCT ID NCT07411131
Summary
This pilot study aims to see if a new synbiotic supplement called SGR11 can help improve symptoms and gut health in people with inflammatory bowel disease (IBD). Fifty adult participants with mild to moderate ulcerative colitis will take the supplement daily for eight weeks while continuing their regular medications. Researchers will track changes in symptoms, quality of life, and gut bacteria to see if the formula is safe and helpful.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prince of Wales Hospital
Hong Kong, Hong Kong
-
Prince of Wales Hospital
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.